Last 11 quarters of trend data · Industrials · Consulting Services
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
SBC Medical Group Holdings Incorporated's quarterly P/E stands at 8.7x, down 87.0% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 52.2% YoY to 5.2x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 6.65 | 8.69 | 48.74 | 3.83 | 21.86 | 66.86 | 16.65 | 15.95 | 17.68 | 30.10 | 124.28 | 64.13 |
| — | -87.0% | +192.7% | -76.0% | +23.6% | +122.1% | -86.6% | -75.1% | — | — | — | — | |
| P/S Ratio | 1.60 | 2.57 | 2.77 | 1.74 | 3.22 | 3.57 | 5.80 | 5.46 | 4.07 | 5.32 | 0.60 | 0.92 |
| — | -28.0% | -52.2% | -68.1% | -21.0% | -32.9% | +873.5% | +495.4% | — | — | — | — | |
| P/B Ratio | 1.59 | 1.80 | 1.96 | 1.46 | 2.93 | 3.69 | 7.66 | 7.91 | 7.05 | 67.17 | 6.47 | 1.36 |
| — | -51.3% | -74.4% | -81.6% | -58.5% | -94.5% | +18.4% | +483.5% | — | — | — | — | |
| P/FCF | 19.17 | — | — | 70.18 | — | 50.41 | 16.79 | 100.36 | 12.03 | 11.52 | — | 13.38 |
| — | — | — | -30.1% | — | +337.7% | — | +650.3% | — | — | — | — | |
| EV / EBITDA | 2.92 | 5.21 | 5.65 | 2.13 | 20.29 | 10.92 | 10.28 | 11.09 | 8.80 | 10.79 | 1.27 | 2.83 |
| — | -52.2% | -45.1% | -80.8% | +130.6% | +1.2% | +707.6% | +292.0% | — | — | — | — | |
| EV / EBIT | 3.08 | 4.66 | 6.31 | 1.68 | 18.88 | 12.37 | 10.67 | 10.39 | 9.91 | 11.94 | 1.57 | 3.55 |
| — | -62.3% | -40.9% | -83.8% | +90.5% | +3.6% | +580.7% | +193.1% | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
SBC Medical Group Holdings Incorporated's operating margin was 36.6% in Q3 2025, up 3.1 pp QoQ and up 10.6 pp YoY. The trailing four-quarter average of 33.0% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 15.3% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 76.0% | 69.0% | 69.2% | 79.7% | 76.3% | 81.5% | 74.2% | 72.1% | 69.6% | 70.9% | 77.9% | 66.5% |
| — | -15.3% | -6.8% | +10.6% | +9.6% | +15.0% | -4.7% | +8.5% | — | — | — | — | |
| Operating Margin | 34.2% | 36.6% | 33.6% | 51.1% | 10.6% | 26.1% | 51.4% | 44.6% | 38.5% | 42.4% | 38.0% | 25.8% |
| — | +40.6% | -34.7% | +14.6% | -72.4% | -38.5% | +35.3% | +72.9% | — | — | — | — | |
| Net Margin | 22.7% | 29.6% | 5.7% | 45.4% | 14.7% | 5.3% | 34.8% | 34.2% | 23.0% | 17.7% | 26.0% | 14.0% |
| — | +454.3% | -83.7% | +32.7% | -36.0% | -69.8% | +33.8% | +144.7% | — | — | — | — |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 27.5% | 5.2% | 1.0% | 10.2% | 3.3% | 1.5% | 11.9% | 12.7% | 18.1% | 55.6% | 16.3% | 5.2% |
| — | +236.4% | -91.2% | -19.8% | -81.9% | -97.2% | -27.2% | +145.7% | — | — | — | — | |
| ROA | 17.8% | 4.0% | 0.8% | 7.8% | 2.3% | 1.0% | 7.3% | 7.4% | 10.2% | 38.8% | 15.0% | 5.0% |
| — | +292.3% | -88.8% | +5.5% | -77.3% | -97.4% | -51.0% | +49.0% | — | — | — | — | |
| ROIC | 72.3% | 9.3% | 10.1% | 19.1% | 4.0% | 11.3% | 23.8% | 24.6% | 45.5% | 98.4% | 17.8% | 7.2% |
| — | -18.1% | -57.5% | -22.5% | -91.3% | -88.5% | +33.3% | +242.5% | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
SBC Medical Group Holdings Incorporated's Debt/EBITDA ratio is 1.7x, up from 1.0x last quarter — comfortably within a safe range. The current ratio has improved 82.6% YoY to 5.10x, strengthening the short-term liquidity position. Debt/Equity has risen for 3 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.06 | 0.11 | 0.06 | 0.06 | 0.06 | 0.14 | 0.18 | 0.20 | 0.16 | 0.07 | 0.07 | — |
| — | -17.5% | -65.4% | -69.3% | -60.6% | +106.0% | +176.8% | — | — | — | — | — | |
| Debt / EBITDA | 0.16 | 1.70 | 1.02 | 0.57 | 2.16 | 1.90 | 1.05 | 1.20 | 0.86 | 0.04 | 0.05 | — |
| — | -10.9% | -2.5% | -52.8% | +151.0% | +4337.5% | +1910.2% | — | — | — | — | — | |
| Current Ratio | 3.01 | 5.10 | 3.98 | 4.44 | 3.01 | 2.79 | 2.26 | 2.15 | 1.79 | 0.30 | 0.46 | 0.56 |
| — | +82.6% | +75.8% | +106.1% | +68.0% | +817.6% | +387.4% | +285.4% | — | — | — | — | |
| Quick Ratio | 2.99 | 5.06 | 3.95 | 4.40 | 2.99 | 2.76 | 2.24 | 2.12 | 1.76 | 0.30 | 0.46 | 0.56 |
| — | +83.1% | +76.6% | +108.0% | +69.8% | +808.6% | +381.8% | +278.8% | — | — | — | — | |
| Interest Coverage | 2484.23 | 326.54 | 293.13 | 3899.16 | 380.40 | 2531.03 | 3675.99 | 8131.94 | 3032.02 | 5033.49 | 1045.13 | — |
| — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 11 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying SBC stock.
SBC Medical Group Holdings Incorporated's current P/E is 6.7x. The average P/E over the last 4 quarters is 20.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
SBC Medical Group Holdings Incorporated's current operating margin is 34.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking SBC Medical Group Holdings Incorporated's business trajectory between earnings reports.